“…Through modulating pyrimidine biosynthesis, inhibitors of dihydroorotate dehydrogenase (DHODH) have proved to be clinically useful in the treatment of autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, transplant rejection and psoriatic arthritis (Norman, 2013;Munier-Lehmann et al, 2013). Many inhibitors have also been investigated to treat cancer (Dell, 1998;Hurt et al, 2006;Vyas et al, 2014;Abdullah et al, 2015) and viral (Zhang et al, 2012) and parasite infections (i.e. malaria) (Seymour et al, 1994;Booker et al, 2010;Skerlj et al, 2011), as well being used as antifungal agents (Gustafson et al, 1996), antibiotics (Marcinkeviciene et al, 2000;Copeland et al, 2000) and in crop science (Longhurst et al, 1996).…”